Nasal Reconstruction Using a Customized 3D-printed Nasal Stent for Congenital Arhinia

A 7-year-old arhinia patient receives nasal reconstruction with nasal cavity reconstruction and is aided with the application of a 3D-printed nasal stent to prevent nasal cavity constriction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arhinia Arrhinia

Sex eligibility

Male

Study type

Observational

About this study

After reconstruction of a nasal cavity in the maxilla by burring using a navigation system, the patient required a nasal stent to prevent stenosis. However there was no conventional stent available. A 3D-printed silicone nasal stent was custom made for the cavity and inserted.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Single patient
7-year-old male
Congenital arhinia
No history of previous treatment

Exclusion criteria

Treatment and study plan

Customized 3D-printed nasal stent

Other

Silicone stent with unconventional shape, 3D-printed based on patient's computed topographical images, to exactly fit newly made nasal cavity.

Primary outcomes

Nasal cavity diameter

Time frame: 6 months

Change from baseline nasal cavity diameter (measured by CT sagittal section, in millimeters)

Sponsors and collaborators

Lead sponsor

Seoul St. Mary's Hospital

Other

Collaborators

Pohang University of Science and Technology

Registry information

Important dates

Study start: 2013
Primary completion: 2013
Study completion: 2013
First posted: Sep 24, 2015
Registry last updated: Sep 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.